
Annual Report 2020
LETTER FROM THE CEO
Globally, 2020 began as one of the healthiest years on record. Decades of work to strengthen primary care infrastructure, combat the spread of infectious diseases, and improve nutritional outcomes had helped to provide more people than ever before with the opportunity to lead healthy and productive lives.
By mid-year, COVID-19 had upended much of that progress around the world. What started as an acute health crisis quickly permeated all facets of life, with far-reaching social and economic consequences. Hard-earned gains in all spheres of development—not just global health, but also economic growth, education, and poverty alleviation—stalled or regressed.
On the backdrop of that turmoil, the murders of Black people in the United States, including George Floyd, Breonna Taylor, and Ahmaud Arbery, sparked a global movement to confront injustice and inequality. The spate of hate-based attacks against Asians throughout the year only heightened the urgency of that cause.
For many, 2020 will forever be linked with trauma and hardship. The number of lives lost and pain endured was staggering. But that will not be the year’s only legacy.
It was also a year when we collectively adapted to the unfamiliar and found new ways to carry out our important work, even amidst the most trying of circumstances. A year when the institutions we built, nurtured, and resourced together with our partners for moments like this rose to the challenge. And a year when unprecedented collaboration between scientists around the world produced the fastest vaccine turnaround time in history.
Our close partnerships with you—the tireless advocates and dedicated professionals across the public, private, and philanthropic sectors—were indispensable to each of those successes. Those partnerships will continue to be integral as we work together to bring the pandemic under control and rebuild a more equitable and resilient world. As we strive to do so, we remain committed to transparency, accountability, and responsible stewardship of the financial resources generously entrusted to us.
To that end, I am pleased to share with you the Bill & Melinda Gates Foundation’s 2020 Annual Report. Our complete audited financial statements are available on gatesfoundation.org and provide a clear and comprehensive picture of our ongoing efforts to carry out that stewardship.
This commitment is essential to achieve the impact we seek. Through judicious use of our resources, we can ensure that as much of it as possible goes toward reducing poverty, disease, and inequality.
It is an honor to join forces in that endeavor with our outstanding friends, partners, and grantees across the United States and around the world. To all of you, I extend my deepest thanks.

Mark Suzman
Chief Executive Officer
Bill & Melinda Gates Foundation
Share the report
Funding summary
In 2020, the foundation provided US$5.822 in direct grantee support in the following areas.
$1.893B
Innovation saves lives and transform livelihoods in the world’s poorest communities. The Global Development Division works on breakthroughs in science and technology that will make the biggest difference to the most people.
$1.793B
When health improves, life improves by every measure. The Global Health Division works to reduce the burden of infectious diseases, and the leading causes of death for women and children in developing countries.
$642M
Education is a bridge to opportunity like no other. We work to get more students of color and those from low-income backgrounds to and through college—including by tackling barriers outside the classroom.
$620M
Healthy, thriving people build healthy, thriving economies. The Global Growth & Opportunity Division works to help people lift themselves out of poverty, and deliver sustainable, inclusive growth that benefits everyone.
$523M
Partnerships ensure the greatest impact in the areas of greatest need. The Global Policy & Advocacy Division builds strategic alliances to promote policies that advance our mission, and raise awareness of urgent global issues.
$258M
$94M
There is nowhere on Earth where women are equal to men. In 2020, we created a Gender Equality Divsion that focuses on women’s economic empowerment, and ensuring that gender is integrated with all our work.
*Financial figures are rounded to the nearest million and include grants and direct charitable expenses (DCE), but not Program Related Investments (PRIs), for year ended December 31, 2020.
| Global Development | $1,893,000,000* |
|---|---|
| Polio | $616,000,000 |
| Global Delivery Programs | $524,000,000 |
| Family Planning | $253,000,000 |
| Maternal, Newborn & Child Health | $122,000,000 |
| Africa Offices | $109,000,000 |
| India Office | $108,000,000 |
| Nutrition | $107,000,000 |
| Multilateral Partnerships | $25,000,000 |
| Emergency Response | $22,000,000 |
| Global Development Special Initiatives | $7,000,000 |
| Global Health | $1,792,000,000* |
|---|---|
| Malaria | $263,000,000 |
| Vaccine Development | $220,000,000 |
| HIV | $196,000,000 |
| Innovative Technology Solutions | $167,000,000 |
| Discovery & Translational Sciences | $165,000,000 |
| Maternal, Newborn & Child Health Discovery & Tools | $137,000,000 |
| Tuberculosis | $134,000,000 |
| Pneumonia | $110,000,000 |
| Global Health Special Initiatives | $99,000,000 |
| Neglected Tropical Diseases | $95,000,000 |
| Enteric and Diarrheal Diseases | $92,000,000 |
| Integrated Development | $78,000,000 |
| Innovative Introduction | $36,000,000 |
| United States Program | $642,000,000* |
|---|---|
| K-12 Education | $329,000,000 |
| Postsecondary Success | $125,000,000 |
| Washington State | $47,000,000 |
| U.S. Economic Mobility & Opportunity | $45,000,000 |
| United States Program Special Initiatives | $37,000,000 |
| Pathways | $24,000,000 |
| Scholarships | $23,000,000 |
| Early Learning | $12,000,000 |
| Global Growth & Opportunity | $620,000,000* |
|---|---|
| Agricultural Development | $383,000,000 |
| Financial Services for the Poor | $131,000,000 |
| Water, Sanitation & Hygiene | $101,000,000 |
| Global Growth & Opportunity Special Initiatives | $5,000,000 |
| Global Policy & Advocacy | $523,000,000* |
|---|---|
| Global Fund Core Contributions | $247,000,000 |
| Global Program Advocacy & Communications ** | $59,000,000 |
| Philanthropic Partnerships | $52,000,000 |
| U.S. Program Advocacy & Communications ** | $48,000,000 |
| Donor Government Relations | $40,000,000 |
| Tobacco Control | $28,000,000 |
| Development Policy & Finance | $26,000,000 |
| China Office | $20,000,000 |
| Global Policy & Advocacy Special Initiatives | $3,000,000 |
| Other Charitable Programs | $258,000,000* |
|---|
| Gender Equality | $94,000,000* |
|---|---|
| Gender Equality | $90,000,000 |
| Gender Equality Special Initiatives | 4,000,000 |
* Financial figures are rounded to the nearest million and include grants and direct charitable expenses (DCE), but not Program Related Investments (PRIs), for year ended December 31, 2020.
** Amount does not include advocacy and policy spending specific to individual strategies.